Observational Study of Rapid Sequence Intubation Drug Delivery Using Intraosseous and Intravenous Access.

Vidacare

Status: Terminated

Conditions: Airway Control

Study type: Observational

Funder types: Industry

Identifiers

NCT01486407

2011-13

Details and patient eligibility

About

This study will evaluate using intraosseous vascular access and intravenous vascular access to give patients the necessary medications to perform rapid sequence intubation, for patients with airway difficulties. The investigators think the device operator will find the intraosseous and intravenous routes equal for drug delivery.

Full description

This observational study will evaluate the intubating conditions of patients receiving rapid sequence intubation when receiving paralytic drug delivery via intravenous or intraosseous vascular access from the perspective of the medical professional performing rapid sequence intubation. The investigators believe that medical professionals will find equal intubating conditions for intravenous and intraosseous drug delivery.

Enrollment: 4 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Requires rapid sequence intubation
• Succinylcholine is chosen paralytic agent
• Intravenous (IV) or Intraosseous (IO) access has been established for rapid sequence intubation
• For IV access patients, their rapid sequence intubation case is the next occurring IV rapid sequence intubation case following an enrolled IO Rapid Sequence Intubation (RSI) case.

Exclusion criteria

• Vascular access other than IV or IO has been established

Trial design

4 participants in 2 patient groups

Intravenous (IV) drug delivery

Description:

patients on whom intravenous vascular access has been established for the purpose of rapid sequence intubation drug delivery.

Intraosseous (IO) drug delivery

Description:

Patients on whom intraosseous vascular access has been established for rapid sequence intubation drug delivery.